Dupilumab treatment of a case of asthma, chronic rhinosinusitis, and atopic dermatitis after initial benralizumab administration

Dupilumab treatment of a case of asthma, chronic rhinosinusitis, and atopic dermatitis after initial benralizumab administration

Bibliographic Details
Main Authors:	Haruna Matsuda‐Hirose, Naoko Takeo, Masaru Ando, Yumi Kizu, Yutaka Hatano
Format:	Article
Language:	English
Published:	Wiley 2020-08-01
Series:	Journal of Cutaneous Immunology and Allergy
Online Access:	https://doi.org/10.1002/cia2.12115

Similar Items

Cycling therapy with benralizumab and dupilumab for severe eosinophilic asthma with eosinophilic chronic rhinosinusitis and eosinophilic otitis media
by: Satoshi Hamada, et al.
Published: (2021-07-01)

Successful management of eosinophilic chronic rhinosinusitis complicated by severe asthma using dupilumab, following negative initial results with benralizumab
by: Isao Suzaki, et al.
Published: (2021-01-01)

Comparative Efficacy and Safety of Dupilumab and Benralizumab in Patients with Inadequately Controlled Asthma: A Systematic Review
by: Koichi Ando, et al.
Published: (2020-01-01)

Diagnosis of Mycosis Fungoides Following Administration of Dupilumab for Misdiagnosed Atopic Dermatitis
by: Takahito Chiba, et al.
Published: (2019-05-01)

Drug survival rate of dupilumab in Japanese patients with atopic dermatitis
by: Susumu Ichiyama, et al.
Published: (2021-10-01)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
by: Amanda E. Zubek, MD, PhD, et al.
Published: (2021-01-01)

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
by: Sandra Ferreira, et al.
Published: (2020-05-01)

Alopecia areata after dupilumab for atopic dermatitis
by: Krystal Mitchell, MBA, et al.
Published: (2018-03-01)

Real‐world use of dupilumab for 53 patients with atopic dermatitis in Japan
by: Masako Matsutani, et al.
Published: (2020-04-01)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
by: Sung Kyung Cho, BA, et al.
Published: (2021-10-01)

Anaphylactic risk related to omalizumab, benralizumab, reslizumab, mepolizumab, and dupilumab
by: Lisha Li, et al.
Published: (2021-06-01)

Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
by: Adrien Maudinet, et al.
Published: (2019-06-01)

Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis
by: John E. Call, et al.
Published: (2020-08-01)

Dupilumab-induced phenotype switching from atopic dermatitis to psoriasis
by: Aakaash Varma, BA, et al.
Published: (2020-03-01)

Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis
by: Lina U. Ivert, et al.
Published: (2019-02-01)

Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis
by: Emilie Fowler, et al.
Published: (2019-06-01)

443 Dupilumab for Children and Adolescents with Atopic Dermatitis: An Asian Perspective
by: Shi Yun Chia, et al.
Published: (2021-04-01)

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
by: Danielle M. Peterson, MD, et al.
Published: (2021-04-01)

Spontaneous resolution of atopic dermatitis incidental to participation in benralizumab clinical trial for severe, uncontrolled asthma: a case report
by: David N. Pham
Published: (2021-03-01)

Corneal ulceration associated with dupilumab use in a patient with atopic dermatitis
by: Gavin Li, et al.
Published: (2020-09-01)

A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
by: Marissa Ayasse, BS, et al.
Published: (2021-01-01)

Immune Thrombocytopenic Purpura in a Patient with Atopic Dermatitis Treated with Dupilumab
by: Surina Frey, et al.
Published: (2021-03-01)

Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis
by: Hiroaki Tsurumaki, et al.
Published: (2019-07-01)

Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World Practice
by: Dong Hyek Jang, et al.
Published: (2020-06-01)

Relapsing-remitting multiple sclerosis arising in a patient with atopic dermatitis on dupilumab
by: Leah Laageide, MD, et al.
Published: (2021-09-01)

Dupilumab: safer and more efficient than immunosuppressive drugs in severe atopic dermatitis
by: Mara Giavina-Bianchi, et al.
Published: (2020-08-01)

Transitory Dissemination of Molluscum Contagiosum in a Patient Treated with Dupilumab for Atopic Dermatitis
by: Silvia Ferrucci, et al.
Published: (2020-07-01)

Psoriasis appearing after dupilumab therapy in atopic dermatitis: A case report
by: Ho Seung Kim, et al.
Published: (2020-07-01)

Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
by: Mara Huffenbaecher Giavina-Bianchi, et al.

Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab
by: Sean J. Igelman, BS, et al.
Published: (2020-02-01)

Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy
by: D’Erme AM, et al.
Published: (2017-05-01)

A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis
by: Masahiro Kamata, et al.
Published: (2021-09-01)

Efficacy and use of benralizumab in patients with eosinophilic chronic rhinosinusitis
by: G.L. Fadda, et al.
Published: (2021-03-01)

Changes in Skin and Nasal Microbiome and Staphylococcal Species Following Treatment of Atopic Dermatitis with Dupilumab
by: Caroline Meyer Olesen, et al.
Published: (2021-07-01)

Dupilumab Effects on Innate Lymphoid Cell and Helper T Cell Populations in Patients with Atopic Dermatitis
by: Yasutomo Imai, et al.
Published: (2021-03-01)

Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients
by: Simona Tavecchio, et al.
Published: (2020-08-01)

Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: A case report
by: Madeeha Mian, MD, et al.
Published: (2020-10-01)

Dupilumab therapy rapidly improved alopecia areata associated with trichotillomania in an atopic dermatitis patient
by: Manaka Ushida, et al.
Published: (2020-07-01)

Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
by: Adrien Mareschal, et al.
Published: (2020-01-01)

Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers
by: Helen He, et al.
Published: (2020-08-01)

Cannot write session to /tmp/vufind_sessions/sess_9ivskuvp8ntpd4helvtf4nitdq